Name | (2-methyl-6-nitro-3H-imidazo[2,1-b][1,3]oxazol-2-yl)methanol |
---|---|
Synonyms |
(R)-(2-Methyl-6-nitro-2,3-dihydro-imidazo[2,1
(2-METHYL-6-NITRO-2,3-DIHYDRO-IMIDAZO[2,1-B]OXAZOL-2-YL)-METHANOL 2-hydroxymethyl-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazole (2-methyl-6-nitro-3H-imidazo[2,1-b]oxazol-2-yl)methanol (2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b][1,3]oxazol-2-yl)methanol |
Density | 1.69g/cm3 |
---|---|
Boiling Point | 400.7ºC at 760 mmHg |
Molecular Formula | C7H9N3O4 |
Molecular Weight | 199.16400 |
Flash Point | 196.1ºC |
Exact Mass | 199.05900 |
PSA | 93.10000 |
LogP | 0.45790 |
Index of Refraction | 1.691 |
HS Code | 2934999090 |
---|
~94% 681491-12-3 |
Literature: Global Alliance for TB Drug Development Patent: US2011/28466 A1, 2011 ; Location in patent: Page/Page column 14 ; |
HS Code | 2934999090 |
---|---|
Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |